Related Experiment Video
Updated: Sep 16, 2025

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Interplay Between Myocardial Bridging, Atherosclerosis, and Spasm in Patients With Nonobstructive Coronary Arteries
Alexandra Bastiany1, Laurie-Anne Boivin-Proulx2, Tess E Allan3
1Department of Cardiology, Thunder Bay Regional Health Sciences Center, Thunder Bay, Ontario, Canada.
Insights
Myocardial bridging (MB) and moderate atherosclerosis significantly increase the risk of epicardial spasm. Patients with both conditions experience the highest prevalence of spasm, highlighting a critical link in coronary artery disease.
Area of Science:
- Cardiology
- Vascular Biology
- Diagnostic Imaging
Background:
- Previous research indicated separate links between myocardial bridging (MB), atherosclerosis, and epicardial vasospasm.
- The combined impact of these conditions on coronary artery function, particularly in North America, remained understudied.
Purpose of the Study:
- To investigate the prevalence and interplay of myocardial bridging, moderate atherosclerosis, and epicardial spasm in a North American cohort.
- To determine if MB and moderate atherosclerosis are independent risk factors for epicardial spasm.
Main Methods:
- Invasive coronary function testing (adenosine and acetylcholine provocation) was performed on 472 patients with angina and nonobstructive coronary arteries.
- Epicardial spasm was defined as new >90% stenosis post-acetylcholine.
- The presence of MB and moderate atherosclerosis (>50% stenosis or stented with negative FFR) was assessed.
Main Results:
- Epicardial spasm occurred in 27.8% of patients.
- Patients with MB (43.7%) and moderate atherosclerosis (39.6%) had significantly higher rates of spasm compared to those without.
- The highest prevalence of epicardial spasm (61.9%) was observed in patients with both MB and moderate atherosclerosis.
Conclusions:
- Myocardial bridging and moderate atherosclerosis are independently associated with an increased risk of epicardial spasm.
- Epicardial vasospasm is most prevalent in individuals presenting with the combined presence of myocardial bridging and moderate atherosclerosis.
Background:
Previous evidence suggested individual associations between myocardial bridging (MB), atherosclerosis, and epicardial vasospasm. The complex interplay between these 3 identities has not been well studied in the North American population.
Methods:
All patients with angina and nonobstructive coronary arteries referred for coronary angiogram who underwent invasive coronary function testing (adenosine and acetylcholine provocation testing) at 2 North American centers between March 2016 and January 2021 were included. The prevalence of epicardial spasm (new >90% stenosis after acetylcholine injection) was assessed according to the presence of MB and moderate atherosclerosis (>50% stenosis or previously stented with negative fractional flow reserve).
Results:
In total, 472 patients were included, from whom 18.4% (n = 87) had MB and 30.5% (n = 144) had moderate atherosclerosis. The overall prevalence of epicardial spasm was 27.8% (n = 132). Epicardial spasm occurred in 43.7% (n = 38) in patients with MB vs 24.4% (n = 94) in patients without MB (P < .01), while it occurred in 39.6% (n = 57) in patients with moderate atherosclerosis vs 22.9% (n = 75) in patients with either mild or no atherosclerosis (P < .01 for each). Epicardial spasm occurred in 19.1% (n = 50) of patients with neither moderate atherosclerosis nor MB, 35.8% (n = 44) of patients with moderate atherosclerosis alone, 37.9% (n = 25) of patients with MB alone, and 61.9% (n = 13) of patients with both MB and moderate atherosclerosis (P < .01). Multivariate analysis confirmed that MB (odds ratio, 2.93; 95% CI, 1.67-5.13; P < .01) and moderate atherosclerosis were independently associated with epicardial spasm (odds ratio, 2.32; 95% CI, 1.18-4.59; P = .02).
Conclusions:
Epicardial vasospasm occurs most frequently in patients with both MB and moderate atherosclerosis.
More Related Videos
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Angina I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Myocarditis I: Introduction

